Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05826132 · ClinicalTrials.gov registry record · NA
Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2
A NA study, sponsored by Research Foundation for Mental Hygiene.
- Completed
- Registry status
- NA
- Development phase
- 1,402
- Enrollment target
NCT05826132: Completed NA study, sponsored by Research Foundation for Mental Hygiene.
NCT05826132 is a NA study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 1,402 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05826132, a NA study, has completed, sponsored by Research Foundation for Mental Hygiene.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,402 participants
- Enrollment target
Study Summary
The mental health consequences of the COVID-19 (Coronavirus Disease of 2019) pandemic are likely to be vast, exceeding the capacity of mental health services and delaying treatment for people in need, with devastating consequences for those affected. Emerging data suggest that frontline health workers (e.g. physicians, nurses, emergency medical technicians) and essential workers (in industries such as energy, and food products and services) face particular risks for mental health problems during and after the COVID-19 outbreak. Additionally, our previous findings have shown that among these higher risk individuals, young adults and women reported greater levels of clinical symptoms. To address the unprecedented mental health needs during and as a result of the COVID-19 pandemic this study will develop and test novel, cost-effective and scalable, digitally-delivered mental health interventions, and will test this approach by focusing on health care workers and other essential workers with an eye toward the young adult portion of this population.
Primary Outcome
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Interventions
- OTHER Adjusted Content Intervention
- OTHER Non-Adjusted Intervention Video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,402 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
What the finished NCT05826132 record still lists
NCT05826132 is an interventional study that assigns participants to a tested intervention. Its 1,402 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Adjusted Content Intervention is the first listed.
NCT05826132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05826132 about?
NCT05826132 is a clinical study titled "Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2". The mental health consequences of the COVID-19 (Coronavirus Disease of 2019) pandemic are likely to be vast, exceeding the capacity of mental health services and delaying treatment for people in need, with devastating consequences for those affected. Emerging data suggest that frontline health worke...
What is the current status of trial NCT05826132?
This trial is currently completed. It is a NA study. The enrollment target is 1,402 participants. The study started on 2023-05-01. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT05826132?
The interventions under investigation include: Adjusted Content Intervention (OTHER), Non-Adjusted Intervention Video (OTHER).
Who is sponsoring clinical trial NCT05826132?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05826132's enrollment target sits among peer trials
1,402 71st of 2000 higher than 1,930 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05444582 · 1,404 participants · Phase 4
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI